Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,092 | 151 | 97.2% |
| Education | $88.32 | 2 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $597.51 | 36 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $560.46 | 32 | $0 (2024) |
| LANTHEUS MEDICAL IMAGING, INC. | $515.23 | 23 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $310.72 | 15 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $249.96 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $232.43 | 14 | $0 (2023) |
| Astellas Pharma US Inc | $220.31 | 4 | $0 (2022) |
| Gilead Sciences, Inc. | $109.65 | 8 | $0 (2019) |
| CSL Behring | $80.00 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $66.56 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $319.85 | 14 | Amgen Inc. ($93.67) |
| 2023 | $319.15 | 16 | Amgen Inc. ($110.80) |
| 2022 | $456.02 | 18 | Janssen Pharmaceuticals, Inc ($165.52) |
| 2021 | $33.13 | 2 | Janssen Pharmaceuticals, Inc ($33.13) |
| 2020 | $97.50 | 4 | Lantheus Medical Imaging, Inc. ($70.85) |
| 2019 | $344.52 | 18 | Astellas Pharma US Inc ($98.28) |
| 2018 | $777.44 | 38 | Lantheus Medical Imaging, Inc. ($197.52) |
| 2017 | $832.77 | 43 | Lantheus Medical Imaging, Inc. ($180.76) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Cardiology | ||||||
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: DIABETES | ||||||
| 09/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: DIABETES | ||||||
| 08/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Cardiology | ||||||
| 06/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Cardiology | ||||||
| 06/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.32 | General |
| Category: Cardiovascular | ||||||
| 05/01/2024 | LANTHEUS MEDICAL IMAGING, INC. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: CONTRAST AGENT | ||||||
| 04/25/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/15/2024 | CSL Behring | Kcentra (Biological) | Education | In-kind items and services | $80.00 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 04/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.46 | General |
| Category: Cardiovascular | ||||||
| 03/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Cardiology | ||||||
| 02/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: DIABETES | ||||||
| 02/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Cardiology | ||||||
| 12/08/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Cardiology | ||||||
| 10/12/2023 | Lantheus Medical Imaging, Inc. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: CONTRAST AGENT | ||||||
| 09/11/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.72 | General |
| Category: Cardiovascular | ||||||
| 08/23/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Cardiology | ||||||
| 07/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: DIABETES | ||||||
| 07/18/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Cardiology | ||||||
| 07/12/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 06/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/10/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: DIABETES | ||||||
| 05/02/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Cardiology | ||||||
| 04/20/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 155 | 162 | $66,566 | $13,239 |
| 2022 | 4 | 284 | 306 | $110,130 | $23,220 |
| 2021 | 4 | 229 | 242 | $91,945 | $19,841 |
| 2020 | 6 | 442 | 466 | $144,278 | $25,581 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 50 | 56 | $34,918 | $6,712 | 19.2% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 53 | 53 | $21,912 | $4,491 | 20.5% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 27 | 28 | $6,044 | $1,236 | 20.5% |
| 99282 | Emergency department visit with straightforward medical decision making | Facility | 2023 | 25 | 25 | $3,691 | $799.75 | 21.7% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 108 | 114 | $77,406 | $16,446 | 21.2% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 35 | 36 | $16,537 | $3,234 | 19.6% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 52 | 53 | $12,685 | $2,923 | 23.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 89 | 103 | $3,502 | $616.02 | 17.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 89 | 91 | $61,789 | $13,326 | 21.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 40 | 40 | $18,440 | $3,877 | 21.0% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 37 | 38 | $9,234 | $2,198 | 23.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 63 | 73 | $2,482 | $440.20 | 17.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 119 | 123 | $93,681 | $16,843 | 18.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 46 | 49 | $23,201 | $3,950 | 17.0% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 53 | 55 | $16,359 | $2,000 | 12.2% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2020 | 74 | 74 | $3,478 | $1,307 | 37.6% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2020 | 74 | 74 | $4,070 | $873.12 | 21.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 76 | 91 | $3,490 | $607.77 | 17.4% |
About Dr. Michael Dibella, MD
Dr. Michael Dibella, MD is a Emergency Medicine healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760471072.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Dibella, MD has received a total of $3,180 in payments from pharmaceutical and medical device companies, with $319.85 received in 2024. These payments were reported across 153 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,092).
As a Medicare-enrolled provider, Dibella has provided services to 1,110 Medicare beneficiaries, totaling 1,176 services with total Medicare billing of $81,880. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Buffalo, NY
- Active Since 10/19/2005
- Last Updated 01/31/2018
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760471072
Products in Payments
- Repatha (Biological) $471.65
- Definity (Drug) $405.56
- XARELTO (Drug) $310.72
- PRADAXA (Drug) $304.85
- JARDIANCE (Drug) $255.61
- PRALUENT (Drug) $249.96
- BRILINTA (Drug) $216.11
- Corlanor (Drug) $125.86
- LEXISCAN (Drug) $112.17
- DEFINITY (Drug) $109.67
- Kcentra (Biological) $80.00
- ENTRESTO (Drug) $59.18
- ELIQUIS (Drug) $40.84
- LifeVest (Device) $37.44
- BIOMONITOR (Device) $34.50
- CAMZYOS (Drug) $25.72
- Lexiscan (Drug) $23.67
- VYNDAQEL (Drug) $23.67
- Inpefa (Drug) $17.44
- FUROSCIX (Drug) $17.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Buffalo
Dr. Joseph Bart, D.o, D.O
Emergency Medicine — Payments: $239,379
Michael Manka, Md, MD
Emergency Medicine — Payments: $2,837
Dr. Brian Clemency, Do, DO
Emergency Medicine — Payments: $1,745
Dr. Thomas Krier, Md, MD
Emergency Medicine — Payments: $1,694
Dr. Steven Vets, Do, DO
Emergency Medicine — Payments: $1,190
Dr. Jeffrey Thompson, Md, MD
Emergency Medicine — Payments: $597.37